PLoS ONE (Jan 2023)

Does papillary muscle free strain has predictive value in risk stratification of patients with hypertrophic cardiomyopathy?

  • Atilla Koyuncu,
  • Cennet Yildiz,
  • Lutfu Ocal,
  • Sedat Kalkan,
  • Alev Kılıçgedik,
  • Mustafa Ozan Gürsoy,
  • Ersan Oflar,
  • Gökhan Kahveci

DOI
https://doi.org/10.1371/journal.pone.0282054
Journal volume & issue
Vol. 18, no. 2
p. e0282054

Abstract

Read online

BackgroundPapillary muscle free strain has not been evaluated previously in hypertrophic cardiomyopathy (HCMP) patients. Our aim was to evaluate free papillary muscle free strain in HCMP patients and to find whether it has a value for prediction of sudden cardiac death (SCD) risk score.MethodsTransthoracic echocardiography with tissue Doppler imaging, 2-D speckle tracking imaging (STI) of 55 HCMP patients and 45 controls were performed. HCMP patients were further divided into two groups according to their SCD risk score. Patients with risk score of less than 6 points constituted low/intermediate risk group, whereas patients with risk score of greater or equal to 6 points constituted high risk group.ResultsInterventricular septum, posterior wall, and left ventricular mass index were significantly higher, whereas mitral E/A ratio was significantly lower in HCMP patients compared to controls. Longitudinal apical 4C, 2C, 3C, global longitudinal LV strain, anterolateral papillary muscle (ALPM), posteromedial papillary muscle (PMPM) free strain were significantly reduced in HCMP group compared to control group. Global longitudinal strain and ALPM free strain were significantly lower in patients with high SCD risk score (-14.6 (-17.4 - -13.1) vs -11.6 (-13.2 - -10.1), p = 0.001 and -17.1 (-20.3 - -14.0) vs -9.2 (-12.6 - -7.5), pConclusionPapillary muscle free strain was reduced in HCMP patients. It might be used in risk stratification of these patients.